Modulation of Signature Cancer-Related Genes in Oral Cancer Cells (Ca9-22) by Anethole Treatment: Insights into Therapeutic Potential
2024

Anethole Treatment and Its Effects on Oral Cancer Cells

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hammache Meriem, Benchekroun Sara, Alamri Abdullah, Jalouli Maroua, Yousry A. Mohamed Marwa, Boufahja Fehmi, Chahine Mohamed, Chandad Fatiha, Semlali Abdelhabib

Primary Institution: Faculté de Médecine Dentaire, Université Laval, Québec, QC, Canada

Hypothesis

Anethole treatment modulates signature cancer-related genes in oral cancer cells.

Conclusion

Anethole significantly reduces the proliferation of oral cancer cells and induces apoptosis by altering the expression of key genes involved in cell cycle regulation.

Supporting Evidence

  • Anethole treatment reduced the viability of Ca9-22 cells by more than 40%.
  • Cytotoxicity increased by 4.75-fold upon treatment with anethole.
  • Anethole treatment led to significant changes in cell cycle distribution.
  • Thirteen genes involved in cell cycle regulation were significantly altered by anethole treatment.

Takeaway

Anethole, a natural compound, can help fight oral cancer by stopping cancer cells from growing and making them die.

Methodology

The study involved treating Ca9-22 oral cancer cells with 10 μM of anethole and assessing cell proliferation, apoptosis, and gene expression using various assays including MTT, LDH, and PCR arrays.

Limitations

The study primarily focuses on in vitro results, which may not fully translate to in vivo conditions.

Statistical Information

P-Value

0.003

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0315085

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication